Discomfort in Upper Airways Due to intubation-a Randomized Controlled Trial

NCT ID: NCT05614609

Last Updated: 2025-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-01

Study Completion Date

2025-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Few studies have compared different methods for optimalizing intubation conditions in general anesthesia. This randomized controlled trial will compare two different methods for intubation in general anesthesia in gastro- or gynecological procedures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In general anesthesia, it is neccessary to secure the airways with an endotracheal tube. There is no international consensus on how intubation is most efficiently conducted. A cochrane review compared using muscular relaxing medication versus not using blocks for intubation. Primary outcomes were intubation conditions and discomfort in upper airways. The authors concluded that research is limited, and that further research is needed. No studies have compared local anesthetic spray on the glottis and muscular relaxing medication in intubation, focusing on discomfort in upper airways. The null-hypothesis of this study is that there is no difference in upper airway discomfort when using local anesthetic spray or muscular relaxing medication. The study will have a randomized controlled design, randomizing patients undergoing gastro- or gynecological procedures in general anesthesia to receiving either rocuronium (muscle relaxing medication) intravenous, or lidocain spray on the glottis before intubation. The primary outcome is postoperativ hoarseness one hour after intubation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Complications Intubation; Difficult or Failed Intubation Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Block randomization through randomization.com. Proprotion of hoarseness grade-2-or-3 = 30 % in spray and 10 % in rocuronium.

59 patients in each arm.

"sig p \<= ,05", H0 = 0 + 1,96\*√\[30(100-30)n + 10(100-10)/n\] Gitt "power \>= ,80" , HAlt = (30-10) - 0,84\*√\[30(100-30/n) + 10(100- 10/n)\]
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Caregivers
A study nurse will prepare sealed envelopes with the study-arm specified inside. Patients fullfilling the inclusion criteria will be invited to participate. Patients will be blinded for study arm. Intubation will be performed by trained intubators. However, due to the medications possible risk for rest-curarisation, the anesthesia personnel will possibly be able to detect intervention. However, care personnel collecting data will not know which study arm the patient belongs to.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lidocaine spray on the glottis

Lidocaine 20 mgl/ml- 4,4 ml will be sprayed on the glottis. Ventilation for 90 sek, intubation

Group Type ACTIVE_COMPARATOR

Lidocaine topical

Intervention Type DRUG

Comparing lidocaine spray and muscle relaxing medication

Muscle relaxing medication

Rocuronium 0,6 mg/kg administered intravenous. Ventilation for 2.5 minutes (150seconds), intubation

Group Type ACTIVE_COMPARATOR

Lidocaine topical

Intervention Type DRUG

Comparing lidocaine spray and muscle relaxing medication

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lidocaine topical

Comparing lidocaine spray and muscle relaxing medication

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Rocurinoum 0.6 mg/kg intravenous

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA (American Association of Anesthesiologists Classification system for physical status) I-III
* Understand and can express themselves in Norwegian
* Able to give informed consent to participate

Exclusion Criteria

* Cave lidocain and/or muscle relaxing medication
* BMI above 40
* Anticipated difficult intubation
* Need for ventricular tube
* Pathology or malformations in upper airways
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ostfold University College

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ann-Chatrin Leonardsen

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ann-Chatrin Linqvist Leonardsen

Kråkerøy, Østfold fylke, Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

References

Explore related publications, articles, or registry entries linked to this study.

Fjaerestad T, Oyras P, Solbakk KI, Leonardsen AL. Upper airway discomfort: a randomized controlled double-blind trial comparing rocuronium and lidocaine spray for intubation. Eur J Med Res. 2025 Jun 20;30(1):498. doi: 10.1186/s40001-025-02798-8.

Reference Type DERIVED
PMID: 40542414 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Sykehuset Østfold

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.